Relationship of ZNF423 and CTSO with breast cancer risk in two randomised tamoxifen prevention trials

PURPOSE: A case-control study from two randomised breast cancer prevention trials of tamoxifen and raloxifene (P-1 and P-2) identified single nucleotide polymorphisms (SNPs) in or near genes ZNF423 and CTSO as factors which predict which women will derive most anti-cancer benefit from selective oest...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Breast Cancer Res Treat
Huvudupphovsmän: Brentnall, Adam R, Cuzick, Jack, Byers, Helen, Segal, Corrinne, Reuter, Caroline, Detre, Simone, Sestak, Ivana, Howell, Anthony, Powles, Trevor J, Newman, William G, Dowsett, Mitchell
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4977422/
https://ncbi.nlm.nih.gov/pubmed/27400912
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3885-x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk